Network origin in P. Campisi first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to P. Campisi via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Doctorate Degree | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| St. John's Medical College | College/University | Doctorate Degree | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NKARTA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Turnstone Biologics, Inc.
 Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member | |
| SENTI BIOSCIENCES, INC. | Biotechnology | President | |
| INSTIL BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| KITE PHARMA INC | Biotechnology | Corporate Officer/Principal | |
| The University of Nebraska-Lincoln | College/University | Doctorate Degree | |
| The Pennsylvania State University | College/University | Masters Business Admin |
Statistics
International
| United States | 13 |
| Canada | 2 |
Sectoral
| Health Technology | 11 |
| Consumer Services | 5 |
Operational
| Chief Tech/Sci/R&D Officer | 7 |
| Doctorate Degree | 3 |
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 2 |
Most connected contacts
| Insiders | |
|---|---|
| Kanya Rajangam | 11 |
| Vijay Chiruvolu | 5 |
| Venkat Ramanan | 1 |
- Stock Market
- Insiders
- P. Campisi
- Company connections
